A carregar...
Neutralizing monoclonal antibodies for COVID-19 treatment and prevention
The SARS-CoV-2 pandemic has caused unprecedented global health and economic crises. Several vaccine approaches and repurposed drugs are currently under evaluation for safety and efficacy. However, none of them have been approved for COVID-19 yet. Meanwhile, several nMAbs targeting SARS-CoV-2 spike g...
Na minha lista:
| Publicado no: | Biomed J |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Chang Gung University
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7685954/ https://ncbi.nlm.nih.gov/pubmed/33589377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bj.2020.11.011 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|